About Redwing Pharma Private Limited
Data last updated:
Redwing Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2008PTC184934. Its GSTIN is 27AAECR0709A1ZX (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ruchika Jain and Sheetal Kothari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 110 Krishna Bhavan Annex Bhaktakavi Shivji Devshi Marg Deonar, Mumbai, Maharashtra, India – 400088.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Cr, a decline of 65% compared to the previous year. For the same year it recorded a net profit of ₹81,133 (net margin 0.7%) and EBITDA of ₹2.52 Lakh (EBITDA margin 2.2%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 22% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website redwingpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address110 Krishna Bhavan Annex Bhaktakavi Shivji Devshi Marg Deonar, Mumbai, Maharashtra, India – 400088
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Redwing Pharma Private Limited
The main business activity of Redwing Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Redwing Pharma Private Limited FY 2025 filings available
Redwing Pharma Private Limited reported revenue of ₹1.14 Cr (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Redwing Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 65% fall in the latest year. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Redwing Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹81,133 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Redwing Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Redwing Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Redwing Pharma Private Limited
Redwing Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curewhiz Pharmaceuticals (OPC) Private Limited | ₹1.15 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Sikar, Rajasthan, India |
| Teamg3 Infraprojects Private Limited | ₹1.15 Cr (FY 2025) | •••• | •••• | 2987.0% | •••• | Noida, Uttar Pradesh, India |
| Shri Narayan Mani Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Indore, Madhya Pradesh, India |
| L T & L Pharma Private Limited | ₹1.14 Cr (FY 2017) | •••• | •••• | 316.0% | •••• | Ahmedabad, Gujarat, India |
| Nano Healthcare Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Patna, Bihar, India |
| Redwing Pharma Private Limited this company | ₹1.14 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Mumbai, Maharashtra, India |
| Pazia Pharmaceuticals Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 820.0% | •••• | Jaipur, Rajasthan, India |
| Apn Biotech Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 563.0% | •••• | Noida, Uttar Pradesh, India |
| Vmedicare Private Limited | ₹1.14 Cr (FY 2024) | •••• | •••• | 295.0% | •••• | Kalyan, Maharashtra, India |
| Pyramid Formulations Private Limited | ₹1.14 Cr (FY 2023) | •••• | •••• | 16.0% | •••• | Salem, Tamil Nadu, India |
| Inspride Lab Private Limited | ₹1.14 Cr (FY 2019) | •••• | •••• | 82.0% | •••• | Raipur, Chhattisgarh, India |
Peers are the five companies nearest above and the five nearest below Redwing Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Redwing Pharma Private Limited
Redwing Pharma Private Limited is audited by H A MEHTA & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H A MEHTA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Redwing Pharma Private Limited
Redwing Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchika Jain | Director | 09 Nov 2016 | 9 Years 10 Months | Current |
| Sheetal Kothari | Additional Director | 08 Jan 2026 | 0 Years 9 Months | Current |
Ownership and Shareholding of Redwing Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Redwing Pharma Private Limited
Redwing Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Redwing Pharma Private Limited
Employment history and EPFO contributions of people linked to Redwing Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Redwing Pharma Private Limited
Redwing Pharma Private Limited has 6 board changes on record since 2011: 2 appointments and 4 cessations. The latest: Sheetal Kothari was appointed as Additional Director on 08 Jan 2026.
Credit Ratings, Litigation & Regulatory Alerts for Redwing Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Redwing Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Redwing Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Redwing Pharma Private Limited
Redwing Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECR0709A1ZX | Maharashtra | Active | 01 Jul 2017 |
| 24AAECR0709A1Z3 | Gujarat | Active | 10 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Redwing Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Redwing Pharma Private Limited
Redwing Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 July 2008 (18+ years old) and is registered under CIN U24239MH2008PTC184934.
Redwing Pharma reported revenue of ₹1.14 Cr for FY 2025 (down 65% YoY).
Redwing Pharma has 2 current directors:
- Ruchika Jain - Director
- Sheetal Kothari - Additional Director
Redwing Pharma reported a net profit of ₹81,133 (net margin 0.7%) and EBITDA of ₹2.52 Lakh (EBITDA margin 2.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Redwing Pharma is -45% over three years and -22% over five years. In the latest year (FY 2025) revenue fell 65%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Redwing Pharma is 27AAECR0709A1ZX, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAECR0709A1Z3 (Gujarat).
The CIN (Corporate Identification Number) of Redwing Pharma is U24239MH2008PTC184934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Redwing Pharma was incorporated on 22 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Redwing Pharma by revenue are Curewhiz Pharmaceuticals (OPC) Private Limited, Teamg3 Infraprojects Private Limited, Shri Narayan Mani Private Limited, L T & L Pharma Private Limited, Nano Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Sheetal Kothari was appointed as Additional Director on 08 Jan 2026. Suneel Kumar Jain ceased to be Additional Director on 16 Feb 2018. Ruchika Jain ceased to be Additional Director on 30 Sep 2017. Redwing Pharma has 6 board changes on record in total.
Redwing Pharma can be reached through the website redwingpharma.com. Its registered office is in Mumbai, Maharashtra, India.